You have 9 free searches left this month | for more free features.

haic

Showing 1 - 23 of 23

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Carcinoma, Intrahepatic Cholangiocarcinoma, Gallbladder Cancer Trial (HAIC, Surufatinib, Tislelizumab)

Not yet recruiting
  • Carcinoma
  • +7 more
  • HAIC
  • +2 more
  • (no location specified)
Nov 12, 2023

Unresectable Hepatocellular Carcinoma Trial in Nanchang (D-TACE, HAIC, Lenvatinib)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Nanchang, Jiangxi, China
    The Second Affiliated Hospital of Nanchang University
Oct 14, 2022

Macrotrabecular Massive Hepatocellular Carcinoma Trial in Wuhan (HAIC, Camrelizumab plus Apatinib)

Recruiting
  • Macrotrabecular Massive Hepatocellular Carcinoma
  • HAIC
  • Camrelizumab plus Apatinib
  • Wuhan, Hubei, China
    Hepatic Surgery Center, Tongji Hospital, Tongji Medical College,
May 1, 2023

Hepatocellular Carcinoma Trial in Tianjin (HAIC, Sintilimab, Lenvatinib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • HAIC
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Nov 10, 2022

Hepatocellular Carcinoma Trial in Wuhan (HAIC, Sintilimab, Bevacizumab Biosimilar IBI305)

Recruiting
  • Hepatocellular Carcinoma
  • HAIC
  • +2 more
  • Wuhan, Hubei, China
    Union Hospital affiliated to Tongji Medical College of Huazhong
Nov 8, 2022

Hepatocellular Carcinoma Trial in Guangzhou (HAIC, Zoledronic acid)

Recruiting
  • Hepatocellular Carcinoma
  • HAIC
  • Zoledronic acid
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
May 10, 2023

Unresectable Hepatocellular Carcinoma Trial in Guangzhou (dTACE-HAIC, HAIC, dTACE-HAIC protocol)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • dTACE-HAIC
  • +3 more
  • Guangzhou, Guangdong, China
    the Second Affiliated Hospital of Guangzhou Medical University
Feb 22, 2022

Colorectal Cancer Trial in Shanghai (HAIC, Fruquintinib, Tislelizumab)

Recruiting
  • Colorectal Cancer
  • HAIC
  • +5 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 15, 2022

Colorectal Liver Metastases Trial in Beijing (Tislelizumab, Regorafenib, HAIC)

Recruiting
  • Colorectal Liver Metastases
  • Beijing, Beijing, China
  • +1 more
May 25, 2023

Biliary Tract Adenocarcinoma Trial in Shanghai (HAIC, Gemcitabine, Oxaliplatin)

Enrolling by invitation
  • Biliary Tract Adenocarcinoma
  • HAIC
  • +4 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
May 27, 2022

Hepatocellular Carcinoma Trial in Foshan, Guangzhou (HAIC, FOLFOX 2d, FOLFOX 1d)

Recruiting
  • Hepatocellular Carcinoma
  • HAIC
  • +2 more
  • Foshan, Guangdong, China
  • +2 more
Jul 26, 2022

Colorectal Cancer Trial in Beijing, Dalian, Hohhot (Fruquintinib, HAIC)

Recruiting
  • Colorectal Cancer
  • Beijing, China
  • +2 more
Aug 19, 2022

Hepatocellular Carcinoma Trial (Donafenib, Sintilimab, HAIC)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Dec 21, 2021

Hepatocellular Carcinoma Trial in Tianjin (HAIC, Sintilimab, Bevacizumab Biosimilar)

Recruiting
  • Hepatocellular Carcinoma
  • HAIC
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Jan 16, 2022

Potentially Resection, Hepatocellular Carcinoma Trial in Guangzhou (TACE-HAIC, HAIC)

Recruiting
  • Potentially Resection
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 20, 2021

Unresectable Hepatocellular Carcinoma Trial in Beijing (Camrelizumab, HAIC, TKI)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Beijing, Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Nov 22, 2021

Hepatocellular Carcinoma Trial in Beijing (HAIC, TACE, FOLFOX)

Recruiting
  • Hepatocellular Carcinoma
  • HAIC
  • +4 more
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Jan 10, 2022

Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • HAIC
  • +8 more
  • Quanzhou, Fujian, China
  • +1 more
Jan 26, 2023

Hepatocellular Carcinoma Trial in Tianjin (HAIC, Adebrelimab, Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • HAIC
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Jul 27, 2023

Hepatocellular Carcinoma Trial in Guangzhou (HAIC, Sorafenib)

Completed
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
Nov 16, 2021

Hepatocellular Carcinoma, Portal Vein Thrombosis Trial in Beijing (HAIC, Lenvatinib 1, Camrelizumab 1)

Recruiting
  • Hepatocellular Carcinoma
  • Portal Vein Thrombosis
  • HAIC
  • +4 more
  • Beijing, Beijing, China
    Peking Univerisity Cancer Hospital
Jan 10, 2022

HepatoCellular Carcinoma, Portal Vein Thrombosis Trial in Beijing (HAIC, Sorafenib)

Completed
  • HepatoCellular Carcinoma
  • Portal Vein Thrombosis
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Oct 8, 2021

Hepatocellular Carcinoma Trial in Guangzhou, Kaiping (HAIC, PD-1 antibody, Sorafenib)

Withdrawn
  • Hepatocellular Carcinoma
  • HAIC
  • +2 more
  • Guangzhou, Guangdong, China
  • +2 more
May 2, 2019